The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody–positive dermatomyositisAlexander Oldroyd, Dennis McGonagle, Chandra Chattopadhyay et al.|Lara D. Veeken|2018Cited by 110
Long-term persistence with rituximab in patients with rheumatoid arthritisAlexander Oldroyd, Deborah Symmons, Jamie C. Sergeant et al.|Lara D. Veeken|2018Cited by 33
Comment on: The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody–positive dermatomyositis: ReplyAlexander Oldroyd, Hector Chinoy, Jamie C. Sergeant et al.|Lara D. Veeken|2019Cited by 5
OP0279 The Standardised Mortality Rate in UK Adult-Onset Myositis Patients is Seven Times Higher than the UK General PopulationAlexander Oldroyd, Hector Chinoy, Laura R. Newton et al.|Annals of the Rheumatic Diseases|2015Cited by 1
117 Anti-TIF-1 antibody positivity is associated with a five-fold increase in cancer risk in the idiopathic inflammatory myopathiesAlexander Oldroyd, Hector Chinoy, Jamie C. Sergeant et al.|Lara D. Veeken|2018Cited by 0